Helius Medical Technologies (HSDT) Competitors $0.28 -0.01 (-1.79%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.28 +0.00 (+0.73%) As of 04/17/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSDT vs. PSTV, LUCY, BJDX, QNRX, AMIX, CHEK, NUWE, HSCS, TIVC, and TTOOShould you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Plus Therapeutics (PSTV), Innovative Eyewear (LUCY), Bluejay Diagnostics (BJDX), Quoin Pharmaceuticals (QNRX), Autonomix Medical (AMIX), Check-Cap (CHEK), Nuwellis (NUWE), Heart Test Laboratories (HSCS), Tivic Health Systems (TIVC), and T2 Biosystems (TTOO). These companies are all part of the "medical equipment" industry. Helius Medical Technologies vs. Plus Therapeutics Innovative Eyewear Bluejay Diagnostics Quoin Pharmaceuticals Autonomix Medical Check-Cap Nuwellis Heart Test Laboratories Tivic Health Systems T2 Biosystems Helius Medical Technologies (NASDAQ:HSDT) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability. Does the MarketBeat Community believe in HSDT or PSTV? Plus Therapeutics received 51 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. Likewise, 63.39% of users gave Plus Therapeutics an outperform vote while only 55.56% of users gave Helius Medical Technologies an outperform vote. CompanyUnderperformOutperformHelius Medical TechnologiesOutperform Votes2055.56% Underperform Votes1644.44% Plus TherapeuticsOutperform Votes7163.39% Underperform Votes4136.61% Do analysts recommend HSDT or PSTV? Plus Therapeutics has a consensus target price of $11.17, indicating a potential upside of 1,595.52%. Given Plus Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Plus Therapeutics is more favorable than Helius Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Helius Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Plus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of HSDT or PSTV? 18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 5.1% of Helius Medical Technologies shares are owned by company insiders. Comparatively, 5.5% of Plus Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer HSDT or PSTV? In the previous week, Plus Therapeutics had 3 more articles in the media than Helius Medical Technologies. MarketBeat recorded 4 mentions for Plus Therapeutics and 1 mentions for Helius Medical Technologies. Helius Medical Technologies' average media sentiment score of 1.00 beat Plus Therapeutics' score of 0.10 indicating that Helius Medical Technologies is being referred to more favorably in the media. Company Overall Sentiment Helius Medical Technologies Positive Plus Therapeutics Neutral Which has higher earnings and valuation, HSDT or PSTV? Helius Medical Technologies has higher earnings, but lower revenue than Plus Therapeutics. Plus Therapeutics is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelius Medical Technologies$520K3.24-$8.85M-$5.74-0.05Plus Therapeutics$4.91M2.28-$13.32M-$2.50-0.26 Which has more risk & volatility, HSDT or PSTV? Helius Medical Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, Plus Therapeutics has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Is HSDT or PSTV more profitable? Plus Therapeutics has a net margin of -225.07% compared to Helius Medical Technologies' net margin of -1,764.74%. Plus Therapeutics' return on equity of 0.00% beat Helius Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Helius Medical Technologies-1,764.74% -244.82% -127.10% Plus Therapeutics -225.07%N/A -154.56% SummaryPlus Therapeutics beats Helius Medical Technologies on 11 of the 18 factors compared between the two stocks. Get Helius Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSDT vs. The Competition Export to ExcelMetricHelius Medical TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.69M$3.11B$5.31B$7.35BDividend YieldN/A1.82%5.45%4.34%P/E Ratio-0.0414.8721.9417.82Price / Sales3.2443.57380.6697.73Price / CashN/A44.0938.2534.64Price / Book0.083.336.453.98Net Income-$8.85M$94.03M$3.22B$247.81M7 Day Performance-11.29%0.10%5.85%3.19%1 Month Performance-34.21%-9.43%-9.62%-7.70%1 Year Performance-94.66%-20.15%11.79%1.49% Helius Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSDTHelius Medical Technologies1.0551 of 5 stars$0.28-1.8%N/A-94.5%$1.69M$520,000.00-0.0430Short Interest ↓Positive NewsGap UpPSTVPlus Therapeutics1.7391 of 5 stars$0.83+4.9%$11.17+1,248.6%-59.8%$4.88M$4.91M-0.3320Short Interest ↑Gap DownLUCYInnovative Eyewear0.2275 of 5 stars$1.86-6.1%N/A-63.4%$4.56M$1.64M-0.199Gap DownBJDXBluejay Diagnostics0.4993 of 5 stars$7.50+112.5%N/A-99.1%$4.16M$250,000.00-0.019Short Interest ↑Gap UpHigh Trading VolumeQNRXQuoin Pharmaceuticals1.4575 of 5 stars$0.20-14.0%N/A-77.9%$4.13MN/A-0.054Gap UpAMIXAutonomix Medical2.6822 of 5 stars$1.61-2.1%$28.00+1,639.1%-96.9%$3.97MN/A-0.121Short Interest ↑News CoverageCHEKCheck-Cap1.0556 of 5 stars$0.65-3.1%N/A-70.5%$3.80MN/A-0.2280Analyst ForecastShort Interest ↓News CoverageGap DownNUWENuwellis2.6098 of 5 stars$0.76-8.8%$17.00+2,145.4%-89.6%$3.31M$8.74M-0.0170HSCSHeart Test Laboratories1.981 of 5 stars$2.79+2.8%$13.00+366.8%-67.0%$3.01M$14,700.00-0.3510TIVCTivic Health Systems0.1812 of 5 stars$4.75+6.3%N/A-81.5%$2.91M$780,000.000.0010Short Interest ↑TTOOT2 BiosystemsN/A$0.12-0.8%$5.00+4,066.7%-96.4%$2.53M$7.68M0.00180Analyst ForecastGap Up Related Companies and Tools Related Companies PSTV Competitors LUCY Competitors BJDX Competitors QNRX Competitors AMIX Competitors CHEK Competitors NUWE Competitors HSCS Competitors TIVC Competitors TTOO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSDT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSDT Stock Free HSDT Stock Alerts